Forgoing Treatment at the End of Life in 6 European Countries.

Sociology

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Published

Standard

Forgoing Treatment at the End of Life in 6 European Countries. / Bosshard, Georg; Nilstun, Tore; Bilsen, Johan; et al.
In: JAMA Internal Medicine, Vol. 165, No. 4, 28.02.2005, p. 401-407.

Research output: Contribution to Journal/Magazine › Journal article › peer-review

Harvard

Bosshard, G, Nilstun, T, Bilsen, J, Norup, M, Miccinesi, G, van Delden, JJM, Faisst, K, van der Heide, A & for the European End-of-Life (EURELD) Consortium 2005, 'Forgoing Treatment at the End of Life in 6 European Countries.', JAMA Internal Medicine, vol. 165, no. 4, pp. 401-407. <http://archinte.ama-assn.org/cgi/content/abstract/165/4/401>

APA

Bosshard, G., Nilstun, T., Bilsen, J., Norup, M., Miccinesi, G., van Delden, J. J. M., Faisst, K., van der Heide, A., & for the European End-of-Life (EURELD) Consortium, . (2005). Forgoing Treatment at the End of Life in 6 European Countries. JAMA Internal Medicine, 165(4), 401-407. http://archinte.ama-assn.org/cgi/content/abstract/165/4/401

Vancouver

Bosshard G, Nilstun T, Bilsen J, Norup M, Miccinesi G, van Delden JJM et al. Forgoing Treatment at the End of Life in 6 European Countries. JAMA Internal Medicine. 2005 Feb 28;165(4):401-407.

Author

Bosshard, Georg; ; Nilstun, Tore; ; Bilsen, Johan; et al. / Forgoing Treatment at the End of Life in 6 European Countries. In: JAMA Internal Medicine. 2005 ; Vol. 165, No. 4. pp. 401-407.

Bibtex

@article{bf580351edd84dd3b32e1358b644aa1d,

title = "Forgoing Treatment at the End of Life in 6 European Countries.",

abstract = "Modern medicine provides unprecedented opportunities in diagnostics and treatment. However, in some situations at the end of a patient{\textquoteright}s life, many physicians refrain from using all possible measures to prolong life. We studied the incidence of different types of treatment withheld or withdrawn in 6 European countries and analyzed the main background characteristics.",

author = "Georg; Bosshard and Tore; Nilstun and Johan; Bilsen and Michael; Norup and Guido; Miccinesi and {van Delden}, {Johannes J. M.} and Karin; Faisst and {van der Heide}, Agnes and {for the European End-of-Life (EURELD) Consortium}, .",

year = "2005",

month = feb,

day = "28",

language = "English",

volume = "165",

pages = "401--407",

journal = "JAMA Internal Medicine",

issn = "1538-3679",

publisher = "American Medical Association",

number = "4",

}

RIS

TY - JOUR

T1 - Forgoing Treatment at the End of Life in 6 European Countries.

AU - Bosshard, Georg;

AU - Nilstun, Tore;

AU - Bilsen, Johan;

AU - Norup, Michael;

AU - Miccinesi, Guido;

AU - van Delden, Johannes J. M.

AU - Faisst, Karin;

AU - van der Heide, Agnes

AU - for the European End-of-Life (EURELD) Consortium, .

PY - 2005/2/28

Y1 - 2005/2/28

N2 - Modern medicine provides unprecedented opportunities in diagnostics and treatment. However, in some situations at the end of a patient’s life, many physicians refrain from using all possible measures to prolong life. We studied the incidence of different types of treatment withheld or withdrawn in 6 European countries and analyzed the main background characteristics.

AB - Modern medicine provides unprecedented opportunities in diagnostics and treatment. However, in some situations at the end of a patient’s life, many physicians refrain from using all possible measures to prolong life. We studied the incidence of different types of treatment withheld or withdrawn in 6 European countries and analyzed the main background characteristics.

M3 - Journal article

VL - 165

SP - 401

EP - 407

JO - JAMA Internal Medicine

JF - JAMA Internal Medicine

SN - 1538-3679

IS - 4

ER -

Research

Links